Literature DB >> 20354807

A meta-analysis of randomized controlled trials that compared laparoscopy-assisted and open distal gastrectomy for early gastric cancer.

Hiroshi Ohtani1, Yutaka Tamamori, Kozo Noguchi, Takashi Azuma, Shunsuke Fujimoto, Hiroko Oba, Tetsuya Aoki, Mieko Minami, Kosei Hirakawa.   

Abstract

BACKGROUND: We conducted a meta-analysis to evaluate and compare the advantages of laparoscopy-assisted distal gastrectomy (LADG) over open distal gastrectomy (ODG) for treating early gastric cancer (EGC).
METHODS: We searched MEDLINE, EMBASE, Science Citation Index, and Cochrane Controlled Trial Register for relevant papers published between January 1990 and January 2010 by using the following search terms: laparoscopy-assisted gastrectomy, laparoscopic gastrectomy, and early gastric cancer. The following data were analyzed: operative time, estimated blood loss, number of harvested lymph nodes, time required for resumption of oral intake, duration of hospital stay, frequency of analgesic administration, complications, tumor recurrence, and mortality.
RESULTS: We selected four papers reporting randomized control studies (RCTs) that compared LADG with ODG for EGC. Our meta-analysis included 267 patients with EGC; of these, 134 and 133 had undergone LADG and ODG, respectively. The volume of intraoperative blood loss, frequency of analgesic administration, and rate of complications were significantly lesser for LADG than for ODG. However, the time required for resumption of oral intake and duration of hospital stay did not significantly differ between LADG and ODG. The operative time for LADG was significantly longer than that for ODG; further, the number of harvested lymph nodes was significantly lesser in the LADG group than in the ODG group.
CONCLUSION: LADG is advantageous over ODG because it results in lesser blood loss, is less painful, and is associated with a low risk of complications. Additional RCTs that compare LADG and ODG and investigate the long-term oncological outcomes of LADG are required to determine the advantages of LADG over ODG.

Entities:  

Mesh:

Year:  2010        PMID: 20354807     DOI: 10.1007/s11605-010-1195-x

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  24 in total

1.  Comparison of time trends in stomach cancer mortality (1990-2006) in the world, from the WHO mortality database.

Authors:  Hiroko Yako-Suketomo; Kota Katanoda
Journal:  Jpn J Clin Oncol       Date:  2009-09       Impact factor: 3.019

2.  A randomized controlled trial comparing open vs laparoscopy-assisted distal gastrectomy for the treatment of early gastric cancer: an interim report.

Authors:  Seigo Kitano; Norio Shiraishi; Kyuzo Fujii; Kazuhiro Yasuda; Masafumi Inomata; Yosuke Adachi
Journal:  Surgery       Date:  2002-01       Impact factor: 3.982

3.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

4.  A multicenter study on oncologic outcome of laparoscopic gastrectomy for early cancer in Japan.

Authors:  Seigo Kitano; Norio Shiraishi; Ichiro Uyama; Kenichi Sugihara; Nobuhiko Tanigawa
Journal:  Ann Surg       Date:  2007-01       Impact factor: 12.969

5.  Laparoscopic-assisted proximal gastrectomy for early gastric carcinomas.

Authors:  S Kitano; Y Adachi; N Shiraishi; T Suematsu; T Bando
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

6.  Prospective randomized study of open versus laparoscopy-assisted distal gastrectomy with extraperigastric lymph node dissection for early gastric cancer.

Authors:  H Hayashi; T Ochiai; H Shimada; Y Gunji
Journal:  Surg Endosc       Date:  2005-07-28       Impact factor: 4.584

7.  Laparoscopic and open gastric resections for malignant lesions: a prospective comparative study.

Authors:  J-L Dulucq; P Wintringer; C Stabilini; L Solinas; J Perissat; A Mahajna
Journal:  Surg Endosc       Date:  2005-05-12       Impact factor: 4.584

8.  Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial.

Authors:  Young-Woo Kim; Yong Hae Baik; Young Ho Yun; Byung Ho Nam; Dae Hyun Kim; Il Ju Choi; Jae-Moon Bae
Journal:  Ann Surg       Date:  2008-11       Impact factor: 12.969

9.  National outcomes after gastric resection for neoplasm.

Authors:  Jillian K Smith; James T McPhee; Joshua S Hill; Giles F Whalen; Mary E Sullivan; Demetrius E Litwin; Frederick A Anderson; Jennifer F Tseng
Journal:  Arch Surg       Date:  2007-04

10.  Treatment of gastric adenocarcinoma may differ among hospital types in the United States, a report from theNational Cancer Data Base.

Authors:  Kaye M Reid-Lombardo; Greer Gay; Lina Patel-Parekh; Jaffer A Ajani; John H Donohue
Journal:  J Gastrointest Surg       Date:  2007-03-14       Impact factor: 3.452

View more
  49 in total

1.  Quality of life after laparoscopy-assisted pylorus-preserving gastrectomy: an evaluation using a questionnaire mailed to the patients.

Authors:  Morimasa Tomikawa; Daisuke Korenaga; Tomohiko Akahoshi; Kenichi Kohshi; Keishi Sugimachi; Yoshihiro Nagao; Norifumi Tsutsumi; Kenji Takenaka; Yoshihiro Kakeji; Makoto Hashizume; Yoshihiko Maehara
Journal:  Surg Today       Date:  2012-04-15       Impact factor: 2.549

2.  Short-term surgical outcomes and operative risks of laparoscopic total gastrectomy (LTG) for gastric carcinoma: experience at a large-volume center.

Authors:  Oh Jeong; Seong Yeop Ryu; Xue-Feng Zhao; Mi Ran Jung; Kwang Yong Kim; Young Kyu Park
Journal:  Surg Endosc       Date:  2012-05-31       Impact factor: 4.584

Review 3.  Laparoscopic and robot-assisted gastrectomy for gastric cancer: Current considerations.

Authors:  Stefano Caruso; Alberto Patriti; Franco Roviello; Lorenzo De Franco; Franco Franceschini; Andrea Coratti; Graziano Ceccarelli
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

4.  Laparoscopic versus open distal gastrectomy for locally advanced gastric cancer: a case-control study.

Authors:  Marco Scatizzi; Katrin C Kröning; Elisa Lenzi; Luca Moraldi; Stefano Cantafio; Francesco Feroci
Journal:  Updates Surg       Date:  2011-02-01

5.  Completely laparoscopic versus open gastrectomy for early and advanced gastric cancer: a matched cohort study.

Authors:  Fabrizio Moisan; Enrique Norero; Milenko Slako; Julián Varas; Gonzalo Palominos; Fernando Crovari; Luis Ibañez; Gustavo Pérez; Fernando Pimentel; Sergio Guzmán; Nicolás Jarufe; Camilo Boza; Alex Escalona; Ricardo Funke
Journal:  Surg Endosc       Date:  2011-10-20       Impact factor: 4.584

Review 6.  Robotic gastrectomy for gastric cancer.

Authors:  Masanori Tokunaga; Akio Kaito; Shizuki Sugita; Masahiro Watanabe; Hideki Sunagawa; Takahiro Kinoshita
Journal:  Transl Gastroenterol Hepatol       Date:  2017-06-02

7.  Clockwise, Modularized Lymphadenectomy in Laparoscopic Gastric Cancer Surgery: a New Laparoscopic Surgery Model.

Authors:  Wei-Han Zhang; Kun Yang; Xin-Zu Chen; Ying Zhao; Kai Liu; Wei-Wei Wu; Zhi-Xin Chen; Zong-Guang Zhou; Jian-Kun Hu
Journal:  J Gastrointest Surg       Date:  2018-10-23       Impact factor: 3.452

8.  Postoperative intra-abdominal complications assessed by the Clavien-Dindo classification following open and laparoscopy-assisted distal gastrectomy for early gastric cancer.

Authors:  Masanori Tokunaga; Junya Kondo; Yutaka Tanizawa; Etsuro Bando; Taiichi Kawamura; Masanori Terashima
Journal:  J Gastrointest Surg       Date:  2012-07-31       Impact factor: 3.452

9.  National outcomes and uptake of laparoscopic gastrectomy for cancer in England.

Authors:  Ravikrishna Mamidanna; Alex M Almoudaris; Alex Bottle; Paul Aylin; Omar Faiz; George B Hanna
Journal:  Surg Endosc       Date:  2013-04-24       Impact factor: 4.584

Review 10.  Gastric cancer: Current status of lymph node dissection.

Authors:  Maurizio Degiuli; Giovanni De Manzoni; Alberto Di Leo; Domenico D'Ugo; Erica Galasso; Daniele Marrelli; Roberto Petrioli; Karol Polom; Franco Roviello; Francesco Santullo; Mario Morino
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.